The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents

Experimental Cell Research

Volumn 257, Issue 1, 2000, Pages 127-134

  Rasmussen, Lene Juel ^a,b   Rasmussen, Merete ^a   Lützen, Anne ^a   Bisgaard, Hanne Cathrine ^a   Singh, Keshav K ^b  

^a ROSKILDE UNIVERSITY   (Denmark)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Alkylating agents; Cyclin B1; DU145; LNCaP; Mismatch repair (MMR); Prostate cancer

Indexed keywords

ALKYLATING AGENT; CYCLIN B1; DNA; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CYCLE; DNA REPAIR; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0034713236     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4865     Document Type: Article

References (35)

1. Levine A. J. P53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
2. Linda K., Prives C. p53: Puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
3. Korsmeyer S. J., Shutter J. R., Vers D. J., Merry D. E., Oltavi Z. N. Bcl2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4:1993;327-332.
4. Kreis W. Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer. Cancer Invest. 13:1995;296-312.
5. Singer B., Grunnberger D. Molecular Biology of Mutagens and Carcinogens. 1983;Plenum, New York.
6. Friedberg E. C., Walker G. C., Siede W. DNA Repair and Mutagenesis. 1995;Am. Soc. Microbiol. Washington.
7. 6-methylguanine residue in Escherichia coli DNA. Nature. 296:1982;868-869.
8. Karran P., Bignami M. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res. 12:1992;2933-2940.
9. Karran P., Bignami M. Drug-related killings: A case of mistaken identity. Chem. Biol. 3:1996;875-879.
10. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA. 93:1996;6443-6447.
11. 6-methylguanine DNA lesions. Carcinogenesis. 17:1996;2085-2088.
12. Duckett D., Bronstein S. M., Taya Y., Modrich P. hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage. Proc. Natl. Acad. Sci. USA. 96:1999;12384-12388.
13. Hickman M. J., Samson L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA. 96:1999;10764-10769.
14. Carethers J. M., Hawn M. T., Chauhan D. P., Luce M. C., Marra G., Koi M., Boland C. R. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N′-nitro-N-nitrosoguanidine. J. Clin. Invest. 98:1996;199-206.
15. King R. W., Jackson P. K., Kirschner M. W. Mitosis in transition. Cell. 79:1994;563-571.
16. Kao G. D., McKenna G., Maity A., Blank K., Muschel R. J. Cyclin B1 availability is a rate-limiting component of the radiation-induced G2 delay in HeLa cells. Cancer Res. 57:1997;753-758.
17. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
18. Jäger A. C., Bisgaard M. L., Myrhøj T., Bernstein I., Rehfeld J. F., Nielsen F. C. Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. Am. J. Hum. Genet. 61:1997;129-138.
19. Umar A., Boyer J. C., Thomas D. C., Nguyen D. C., Risinger J. I., Boyd J., Ionov Y., Perucho M., Kunkel T. A. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J. Biol. Chem. 269:1994;14367-14370.
20. Canitrot Y., Frechet M., Servant L., Cazayx C., Hoffmann J. S. Overexpression of DNA polymerase beta: A genomic instability enhancer process. FASEB J. 13:1999;1107-1111.
21. Malkhosyan S., Rampino N., Yamamoto H., Perucho M. Frameshift mutator mutations. Nature. 382:1996;499-500.
22. Leadon S. A., Avrutskaya A. V. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair. Cancer Res. 57:1997;3784-3791.
23. O'Driscoll M., Martinelli S., Ciotta C., Karran P. Combined mismatch and nucleotide excision repair defects in a human cell line: Mismatch repair processes methylation but not UV- or ionizing radiation-induced DNA damage. Carcinogenesis. 20:1999;799-804.
24. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: The role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis. 12:1991;1857-1867.
25. Liu L., Markowitz S., Gerson S. L. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res. 56:1996;5375-5379.
26. Carroll A. G., Voeller H. J., Sugars L., Gelmann E. P. p53 oncogene mutations in three prostate cancer cell lines. Prostate. 23:1993;123-134.
27. el-Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. WAF1/CIP1 is induced in p53 mediated G1 arrest and apoptosis. Cancer Res. 54:1995;1169-1174.
28. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination and cancer biology. Annu. Rev. Biochem. 65:1996;101-133.
29. Rasmussen L. J., Samson L., Marinus M. G. Dam-directed DNA mismatch repair. Hoekstra M. F., Nickoloff J. A. DNA Damage and Repair: Biochemistry, Genetics and Cell Biology. 1998;205-227 Humana Press, Clifton.
30. 6-alkylguanine-DNA alkyltransferase and N,N′-bis(2-chloroethyl)-N-nitrosourea. Biochem. Pharmacol. 50:1995;1141-1148.
31. Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89:1992;7491-7495.
32. McIlwrath A. J., Vasey P. A., Ross G. M., Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild type p53 for radiosensitivity. Cancer Res. 54:1994;3718-3722.
33. Waldman T., Lengauer C., Kinzler K. W., Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature. 381:1996;713-716.
34. Chresta C. M., Masters J. R. W., Hickman J. A. Hypersensitivity of human testicular tumors to etopside-induced apoptosis is associated with functional p53 and high Bax:Bcl2 ratio. Cancer Res. 56:1996;1834-1841.
35. Labreque S., Matlashewski G. I. Viability of wild type p53 containing and p53 deficient tumor cells following anti-cancer treatment: The use of human papillomavirus E6 to target p53. Oncogene. 10:1995;387-392.